Mitochondrial dysfunction and lipid peroxidation in rat frontal cortex by chronic NMDA administration can be partially prevented by lithium treatment

Journal of Psychiatric Research

Volumn 76, Issue , 2016, Pages 59-65

  Kim, Helena K ^a   Isaacs Trepanier, Cameron ^a   Elmi, Nika ^a   Rapoport, Stanley I ^b   Andreazza, Ana C ^a,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b NATIONAL INSTITUTE ON AGING   (United States)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

Excitotoxicity; Lipid peroxidation; Lithium; Mitochondria; NMDA

Indexed keywords

4 HYDROXYNONENAL; 8 ISOPROSTANE; LIPID HYDROPEROXIDE; LITHIUM; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE); UBIQUINOL CYTOCHROME C REDUCTASE; 4-HYDROXY-2-NONENAL; 8-EPI-PROSTAGLANDIN F2ALPHA; ALDEHYDE; AMINO ACID RECEPTOR STIMULATING AGENT; ANTIDEPRESSANT AGENT; MULTIENZYME COMPLEX; N METHYLASPARTIC ACID; PROSTAGLANDIN F2 ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIPOLAR DISORDER; CONTROLLED STUDY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXCITOTOXICITY; FRONTAL CORTEX; GLUTAMATERGIC HYPERACTIVITY; HYPERACTIVITY; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; ANALOGS AND DERIVATIVES; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; FISCHER 344 RAT; FRONTAL LOBE; GENE EXPRESSION REGULATION; METABOLISM; MITOCHONDRIAL DISEASES; NONPARAMETRIC TEST; PATHOLOGY;

ALDEHYDES; ANIMALS; ANTIDEPRESSIVE AGENTS; DINOPROST; DISEASE MODELS, ANIMAL; EXCITATORY AMINO ACID AGONISTS; FRONTAL LOBE; GENE EXPRESSION REGULATION; LIPID PEROXIDATION; LITHIUM; MALE; MITOCHONDRIAL DISEASES; MULTIENZYME COMPLEXES; N-METHYLASPARTATE; RATS; RATS, INBRED F344; STATISTICS, NONPARAMETRIC;

EID: 84960119610     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2016.02.001     Document Type: Article

References (62)

1. Andreazza A.C., Kauer-Sant'anna M., Frey B.N., Bond D.J., Kapczinski F., Young L.T., Yatham L.N. Oxidative stress markers in bipolar disorder: a meta-analysis. J. Affect Disord. 2008, 111:135-144.
2. Andreazza A.C., Wang J.F., Salmasi F., Shao L., Young L.T. Specific subcellular changes in oxidative stress in prefrontal cortex from patients with bipolar disorder. J. Neurochem. 2013 Nov, 127(4):552-561. Epub 2013 Jun 11. 10.1111/jnc.12316.
3. Axelrod J. Receptor-mediated activation of phospholipase A2 and arachidonic acid release in signal transduction. Biochem. Soc. Trans. 1990, 18:503-507.
4. Barzilai A., Yamamoto K. DNA damage responses to oxidative stress. DNA Repair (Amst) 2004, 3:1109-1115.
5. Beal M.F. Oxidatively modified proteins in aging and disease. Free Radic. Biol. Med. 2002, 32:797-803.
6. Bosetti F., Rintala J., Seemann R., Rosenberger T.A., Contreras M.A., Rapoport S.I., Chang M.C. Chronic lithium downregulates cyclooxygenase-2 activity and prostaglandin E(2) concentration in rat brain. Mol. Psychiatry 2002, 7:845-850.
7. Brennan A.M., Suh S.W., Won S.J., Narasimhan P., Kauppinen T.M., Lee H., Edling Y., Chan P.H., Swanson R.A. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat. Neurosci. 2009, 12:857-863.
8. Brown N.C., Andreazza A.C., Young L.T. An updated meta-analysis of oxidative stress markers in bipolar disorder. Psychiatry Res. 2014, 218:61-68.
9. Chang M.C., Grange E., Rabin O., Bell J.M., Allen D.D., Rapoport S.I. Lithium decreases turnover of arachidonate in several brain phospholipids. Neurosci. Lett. 1996, 220:171-174.
10. Chitty K.M., Lagopoulos J., Lee R.S., Hickie I.B., Hermens D.F. A systematic review and meta-analysis of proton magnetic resonance spectroscopy and mismatch negativity in bipolar disorder. Eur. Neuropsychopharmacol. 2013, 23:1348-1363.
11. Clay H.B., Sillivan S., Konradi C. Mitochondrial dysfunction and pathology in bipolar disorder and schizophrenia. Int. J. Dev. Neurosci. 2010, 29:311-324.
12. Clinton S.M., Meador-Woodruff J.H. Thalamic dysfunction in schizophrenia: neurochemical, neuropathological, and in vivo imaging abnormalities. Schizophr. Res. 2004, 69:237-253.
13. Corner M.A., van Pelt J., Wolters P.S., Baker R.E., Nuytinck R.H. Physiological effects of sustained blockade of excitatory synaptic transmission on spontaneously active developing neuronal networks-an inquiry into the reciprocal linkage between intrinsic biorhythms and neuroplasticity in early ontogeny. Neurosci. Biobehav Rev. 2002, 26:127-185.
14. Cui J., Shao L., Young L.T., Wang J.F. Role of glutathione in neuroprotective effects of mood stabilizing drugs lithium and valproate. Neuroscience 2007, 144:1447-1453.
15. Dalleau S., Baradat M., Guéraud F., Huc L. Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance. Cell Death Differ. 2013, 20:1615-1630.
16. Denis M. Structure and function of cytochrome-c oxidase. Biochimie 1986, 68:459-470.
17. Dingledine R., Borges K., Bowie D., Traynelis S.F. The glutamate receptor ion channels. Pharmacol. Rev. 1999, 51:7-61.
18. Doorn J.A., Petersen D.R. Covalent adduction of nucleophilic amino acids by 4-hydroxynonenal and 4-oxononenal. Chem. Biol. Interact. 2003, 143-144:93-100.
19. Fariss M.W., Chan C.B., Patel M., Van Houten B., Orrenius S. Role of mitochondria in toxic oxidative stress. Mol. Interv. 2005, 5:94-111.
20. Felder C.C., Kanterman R.Y., Ma A.L., Axelrod J. Serotonin stimulates phospholipase A2 and the release of arachidonic acid in hippocampal neurons by a type 2 serotonin receptor that is independent of inositolphospholipid hydrolysis. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:2187-2191.
21. Fukunaga K., Soderling T.R., Miyamoto E. Activation of Ca2+/calmodulin-dependent protein kinase II and protein kinase C by glutamate in cultured rat hippocampal neurons. J. Biol. Chem. 1992, 267:22527-22533.
22. Gao X., Xu X., Pang J., Zhang C., Ding J.M., Peng X., Liu Y., Cao J.M. NMDA receptor activation induces mitochondrial dysfunction, oxidative stress and apoptosis in cultured neonatal rat cardiomyocytes. Physiol. Res. 2007, 56:559-569.
23. Gigante A.D., Bond D.J., Lafer B., Lam R.W., Young L.T., Yatham L.N. Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta-analysis. Bipolar Disord. 2012, 14:478-487.
24. Giorgi C., Agnoletto C., Bononi A., Bonora M., De Marchi E., Marchi S., Missiroli S., Patergnani S., Poletti F., Rimessi A., Suski J.M., Wieckowski M.R., Pinton P. Mitochondrial calcium homeostasis as potential target for mitochondrial medicine. Mitochondrion 2011, 12:77-85.
25. Girouard H., Wang G., Gallo E.F., Anrather J., Zhou P., Pickel V.M., Iadecola C. NMDA receptor activation increases free radical production through nitric oxide and NOX2. J. Neurosci. 2009, 29:2545-2552.
26. Gu Z., Nakamura T., Lipton S.A. Redox reactions induced by nitrosative stress mediate protein misfolding and mitochondrial dysfunction in neurodegenerative diseases. Mol. Neurobiol. 2010, 41:55-72.
27. Hama-Tomioka K., Kinoshita H., Nakahata K., Kondo T., Azma T., Kawahito S., Hatakeyama N., Matsuda N. Roles of neuronal nitric oxide synthase, oxidative stress, and propofol in N-methyl-D-aspartate-induced dilatation of cerebral arterioles. Br. J. Anaesth. 2012, 108:21-29.
28. Haupt S., Berger M., Goldberg Z., Haupt Y. Apoptosis - the p53 network. J. Cell Sci. 2003, 116:4077-4085.
29. Janssen R.J., Nijtmans L.G., van den Heuvel L.P., Smeitink J.A. Mitochondrial complex I: structure, function and pathology. J. Inherit. Metab. Dis. 2006, 29:499-515.
30. Jornada L.K., Valvassori S.S., Steckert A.V., Moretti M., Mina F., Ferreira C.L., Arent C.O., Dal-Pizzol F., Quevedo J. Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania. J. Psychiatr. Res. 2011, 45:162-168.
31. Kim H.K., Andreazza A.C., Yeung P.Y., Isaacs-Trepanier C., Young L.T. Oxidation and nitration in dopaminergic areas of the prefrontal cortex from patients with bipolar disorder and schizophrenia. J. Psychiatry Neurosci. 2014, 39:276-285.
32. Lazarewicz J.W., Wroblewski J.T., Costa E. N-methyl-D-aspartate-sensitive glutamate receptors induce calcium-mediated arachidonic acid release in primary cultures of cerebellar granule cells. J. Neurochem. 1990, 55:1875-1881.
33. Lazarewicz J.W., Wroblewski J.T., Palmer M.E., Costa E. Activation of N-methyl-D-aspartate-sensitive glutamate receptors stimulates arachidonic acid release in primary cultures of cerebellar granule cells. Neuropharmacology 1988, 27:765-769.
34. Lemasters J.J., Theruvath T.P., Zhong Z., Nieminen A.L. Mitochondrial calcium and the permeability transition in cell death. Biochim. Biophys. Acta 2009, 1787:1395-1401.
35. Lenaz G. The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology. IUBMB Life 2001, 52:159-164.
36. Li N., Ragheb K., Lawler G., Sturgis J., Rajwa B., Melendez J.A., Robinson J.P. Mitochondrial complex I inhibitor rotenone induces apoptosis through enhancing mitochondrial reactive oxygen species production. J. Biol. Chem. 2003, 278:8516-8525.
37. Machado-Vieira R., Andreazza A.C., Viale C.I., Zanatto V., Cereser V., da Silva Vargas R., Kapczinski F., Portela L.V., Souza D.O., Salvador M., Gentil V. Oxidative stress parameters in unmedicated and treated bipolar subjects during initial manic episode: a possible role for lithium antioxidant effects. Neurosci. Lett. 2007, 421:33-36.
38. Machado-Vieira R., Ibrahim L., Henter I.D., Zarate C.A. Novel glutamatergic agents for major depressive disorder and bipolar disorder. Pharmacol. Biochem. Behav. 2012, 100:678-687.
39. Malhi G.S., Tanious M., Das P., Coulston C.M., Berk M. Potential mechanisms of action of lithium in bipolar disorder. Current understanding. CNS Drugs 2013, 27:135-153.
40. Maurer I.C., Schippel P., Volz H.P. Lithium-induced enhancement of mitochondrial oxidative phosphorylation in human brain tissue. Bipolar Disord. 2009, 11:515-522.
41. Mehta A., Prabhakar M., Kumar P., Deshmukh R., Sharma P.L. Excitotoxicity: bridge to various triggers in neurodegenerative disorders. Eur. J. Pharmacol. 2013, 698:6-18.
42. Montuschi P., Barnes P.J., Roberts L.J. Isoprostanes: markers and mediators of oxidative stress. FASEB J. 2004, 18:1791-1800.
43. Naoi M., Maruyama W., Shamoto-Nagai M., Yi H., Akao Y., Tanaka M. Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Mol. Neurobiol. 2005, 31:81-93.
44. Nascimento C., Kim H.K., Young L.T., Mendonça K.M., Grinberg L.T., Lafer B., Andreazza A.C. Glutathione-mediated effects of lithium in decreasing protein oxidation induced by mitochondrial complex I dysfunction. J. Neural Transm. (Vienna) 2015 Jun, 122(6):741-746. Epub 2014 Sep 27. 10.1007/s00702-014-1318-8.
45. Niki E. Lipid peroxidation: physiological levels and dual biological effects. Free Radic. Biol. Med. 2009, 47:469-484.
46. Ormandy G.C., Song L., Jope R.S. Analysis of the convulsant-potentiating effects of lithium in rats. Exp. Neurol. 1991, 111:356-361.
47. Pellerin L., Wolfe L.S. Release of arachidonic acid by NMDA-receptor activation in the rat hippocampus. Neurochem. Res. 1991, 16:983-989.
48. Pizzimenti S., Ciamporcero E., Daga M., Pettazzoni P., Arcaro A., Cetrangolo G., Minelli R., Dianzani C., Lepore A., Gentile F., Barrera G. Interaction of aldehydes derived from lipid peroxidation and membrane proteins. Front. Physiol. 2013, 4:242.
49. Plitman E., Nakajima S., de la Fuente-Sandoval C., Gerretsen P., Chakravarty M.M., Kobylianskii J., Chung J.K., Caravaggio F., Iwata Y., Remington G., Graff-Guerrero A. Glutamate-mediated excitotoxicity in schizophrenia: a review. Eur. Neuropsychopharmacol. 2014, 24:1591-1605.
50. Pramanik K.C., Boreddy S.R., Srivastava S.K. Role of mitochondrial electron transport chain complexes in capsaicin mediated oxidative stress leading to apoptosis in pancreatic cancer cells. PLoS One 2011, 6:e20151.
51. Rapoport S.I. Lithium and the other mood stabilizers effective in bipolar disorder target the rat brain arachidonic acid cascade. ACS Chem. Neurosci. 2014, 5:459-467.
52. Ray P.D., Huang B.W., Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012, 24:981-990.
53. Rego A.C., Santos M.S., Oliveira C.R. Glutamate-mediated inhibition of oxidative phosphorylation in cultured retinal cells. Neurochem. Int. 2000, 36:159-166.
54. Shao L., Cui J., Young L.T., Wang J.F. The effect of mood stabilizer lithium on expression and activity of glutathione s-transferase isoenzymes. Neuroscience 2008, 151:518-524.
55. Shibata S., Watanabe A., Hamada T., Ono M., Watanabe S. N-methyl-D-aspartate induces phase shifts in circadian rhythm of neuronal activity of rat SCN in vitro. Am. J. Physiol. 1994, 267:R360-R364.
56. Shrotriya S., Deep G., Lopert P., Patel M., Agarwal R., Agarwal C. Grape seed extract targets mitochondrial electron transport chain complex III and induces oxidative and metabolic stress leading to cytoprotective autophagy and apoptotic death in human head and neck cancer cells. Mol. Carcinog. 2015 Dec, 54(12):1734-1747. Epub 2014 Dec 31. 10.1002/mc.22246.
57. Tan H., Young L., Shao L., Che Y., Honer W., Wang J. Mood stabilizer lithium inhibits amphetamine-increased 4-hydroxynonenal-protein adducts in rat frontal cortex. Int J Neuropsychopharmacol 2011, 1-11.
58. Versace A., Andreazza A.C., Young L.T., Fournier J.C., Almeida J.R., Stiffler R.S., Lockovich J.C., Aslam H.A., Pollock M.H., Park H., Nimgaonkar V.L., Kupfer D.J., Phillips M.L. Elevated serum measures of lipid peroxidation and abnormal prefrontal white matter in euthymic bipolar adults: toward peripheral biomarkers of bipolar disorder. Mol. Psychiatry 2014 Feb, 19(2):200-208. Epub 2013 Jan 29. 10.1038/mp.2012.188.
59. Wang J.F., Shao L., Sun X., Young L.T. Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. Bipolar Disord. 2009, 11:523-529.
60. Weber D., Milkovic L., Bennett S.J., Griffiths H.R., Zarkovic N., Grune T. Measurement of HNE-protein adducts in human plasma and serum by ELISA-Comparison of two primary antibodies. Redox Biol. 2013, 1:226-233.
61. Weichel O., Hilgert M., Chatterjee S.S., Lehr M., Klein J. Bilobalide, a constituent of Ginkgo biloba, inhibits NMDA-induced phospholipase A2 activation and phospholipid breakdown in rat hippocampus. Naunyn Schmiedeb. Arch. Pharmacol. 1999, 360:609-615.
62. Zhou R., Yazdi A.S., Menu P., Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 2011, 469:221-225.